Intuitive Surgical, Inc. $ISRG Stock Holdings Boosted by Wedmont Private Capital

Wedmont Private Capital raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,163 shares of the medical equipment provider’s stock after buying an additional 2,785 shares during the quarter. Wedmont Private Capital’s holdings in Intuitive Surgical were worth $3,391,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Central Bank & Trust Co. increased its stake in Intuitive Surgical by 5.5% in the third quarter. Central Bank & Trust Co. now owns 15,244 shares of the medical equipment provider’s stock valued at $6,199,000 after purchasing an additional 796 shares in the last quarter. WoodTrust Financial Corp boosted its position in shares of Intuitive Surgical by 40.8% during the third quarter. WoodTrust Financial Corp now owns 5,870 shares of the medical equipment provider’s stock worth $2,387,000 after purchasing an additional 1,700 shares in the last quarter. Douglas Lane & Associates LLC boosted its position in shares of Intuitive Surgical by 112.6% during the third quarter. Douglas Lane & Associates LLC now owns 102,898 shares of the medical equipment provider’s stock worth $41,842,000 after purchasing an additional 54,499 shares in the last quarter. Breakwater Capital Group acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $203,000. Finally, Legacy Wealth Asset Management LLC grew its holdings in shares of Intuitive Surgical by 62.9% in the 3rd quarter. Legacy Wealth Asset Management LLC now owns 4,857 shares of the medical equipment provider’s stock valued at $1,975,000 after buying an additional 1,876 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Truist Financial dropped their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Bank of America decreased their target price on Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, September 20th. Oppenheimer raised Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price target on the stock in a research report on Wednesday, August 12th. Finally, Mizuho set a $500.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a report on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $502.53.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 1,089 shares of the stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the transaction, the vice president directly owned 1,026 shares in the company, valued at approximately $384,175.44. This trade represents a 51.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the sale, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock valued at $4,891,989 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays upgraded Intuitive Surgical to “strong buy” and initiated coverage at “overweight,” citing the company’s high-quality healthcare-equipment business despite a softer medical-device market. The bullish rating provides a near-term catalyst for the shares. Barclays initiates coverage of Intuitive Surgical
• Positive Sentiment: Piper Sandler also assigned a Buy rating, reinforcing favorable sell-side sentiment around ISRG. Intuitive Surgical gets a Buy from Piper Sandler
• Positive Sentiment: The company’s single-port robotic platform is gaining momentum, with rising procedures, utilization and system placements. Expanding medical indications and international adoption could support longer-term revenue growth. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts’ average recommendation remains bullish, but commentary warns that consensus ratings can be overly optimistic and that ISRG’s valuation leaves limited room for disappointment. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Neutral Sentiment: A reported short-interest figure of zero shares and a zero-day days-to-cover ratio suggests the latest short-interest data may be incomplete or erroneous, limiting its usefulness as a trading signal.
• Negative Sentiment: Jim Cramer expressed concern that Johnson & Johnson and other rivals could intensify competition in robotic surgery, potentially pressuring ISRG’s long-term market position. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Trading Up 2.1%

Shares of NASDAQ ISRG opened at $423.96 on Friday. The firm has a market cap of $149.78 billion, a PE ratio of 48.56, a PEG ratio of 3.13 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a fifty day moving average price of $386.36 and a 200 day moving average price of $411.26.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The firm had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the prior year, the company earned $1.81 EPS. The company’s revenue was up 18.4% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.